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Chapter 1 
Exposure of the Acetylcholine Receptor to the Lipid Bilayer 
ABSTRACT: All four subunits of the nicotinic acetylcholine receptor in mem-
brane vesicles isolated from Torpedo californica have been labeled with the pho-
toactivated hydrophobic probe, [3 H]adamantanediazirine, which selectively labels 
regions of integral membrane proteins in contact with the hydrocarbon core of the 
lipid bilayer. As all of the homologous subunits are exposed to the lipid bilayer, 




Identification of the Subunits of Acetylcholine Receptor 
that Interact with a Cholesterol Photoaffinity Probe 
ABSTRACT: All four subunits of the acetylcholine receptor in membrane vesicles 
isolated from Torpedo californica have been labeled with [3 H]cholesteryl diazoac-
etate. As this probe incorporates into lipid bilayers analogously to cholesterol, 
this result indicates that acetylcholine receptor interacts with cholesterol. This 
investigation also demonstrates that this probe is a useful reagent for studying the 
interaction of cholesterol with membrane proteins. 
Since the photogenerated carbene is situated near the lipid-water interface, 
this probe has potential as a topographic tool for mapping membrane protein struc-
ture. The labeling studies with both [3H]adamantanediazirine and [3 H]cholesteryl 
diazoacetate support the concept that the acetylcholine receptor is a pseudosym-




Synthesis of Fluorine-Containing Agonists 
for the Acetylcholine Receptor 
ABSTRACT: The syntheses of the fluorine-containing agonists for the Torpedo cal-
ifornica nicotinic acetylcholine receptor, fluoroacetylcholine bromide and p-fluoro-
phenyltrimethylammonium iodide, are described. It is demonstrated that both are 
agonists using a cation flux assay with acetylcholine receptor enriched membrane 
vesicles. The potential for their use in ligand binding studies using 19F NMR 
spectroscopy is discussed. 
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Chapter 4 
Affinity Cleavage of the Acetylcholine Receptor: 
Evidence for a Low-Affinity Agonist Binding Site 
ABSTRACT: The affinity cleavage reagent, p-thiocyanophenyltrimethylammonium 
iodide, specifically cleaves a peptide bond of the nicotinic acetylcholine receptor 
in membrane vesicles isolated from Torpedo californica. It is demonstrated that 
this reagent is an agonist using a cation flux assay. The cleavage is blocked by 
stoichiometric quantities of o:-bungarotoxin. The yield of the cleavage reaction 
is reduced with addition of the agonist, phenyltrimethylammonium iodide. This 
affinity cleavage reaction provides evidence for a low-affinity binding site for ago-
nists on the 60K subunit. 
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AChR, acetylcholine receptor. 
a-BgTx, a-bungarotoxin. 
BrACh, bromoacetylcholine. 
BSA, bovine serum albumin. 
CARB, carbamylcholine chloride. 
DAP, bis(3-aminopyridinium)-1,10-decane diiodide. 
DAPA, bis(3-azidopyridinium)-1,10-decane perchlorate. 
ESR, electron spin resonance. 
FAcCh, fiuoroacetylcholine bromide. 
FT-IR, fourier transform infrared. 
HEPES, N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid. 
IANBD, 4-[[(iodoacetoxy)ethyl]methylamino]-7-nitro-2,1,3,-benzoxadiazole. 
IR, infrared. 
MBTA, [4-(N-maleimido)benzyl]trimethylammonium diiodide. 
NaDodS0 4 , sodium dodecyl sulfate. 
NBD, 7-nitro-2,1,3-benzoxadiazole. 
NMR, nuclear magnetic resonance. 
NTCB, 2-nitro-5-thiocyanobenzoic acid. 
PFT, p-fiuorophenyltrimethylammonium iodide. 
PTA, phenyltrimethylammonium iodide. 
TEA, triethylamine. 
THF, tetrahydrofuran. 
TLC, thin-layer chromatography. 





The understanding of the molecular basis of a neurotransmitter receptor has 
been greatly facilitated by the isolation of relatively large quantities of the nico-
tinic acetylcholine receptor (AChR) from the electric organs of marine rays in the 
genus Torpedo. The electric organs are a modified muscle tissue which, in addition 
to being an effective predatory offense (Bray & Hixon, 1978), are a rich source of 
the AChR. In the past ten years, the purification and unequivocal identification 
of the components of the AChR has been demonstrated by reconstitution of func-
tional receptor into membrane vesicles [for a recent review, see Conti-Tronconi 
& Raftery, 1982]. In the last five years, all of the AChR subunits have been 
cloned (cDNAs), sequenced, subunit mRNAs synthesized using in vivo (Mishina 
et al., 1984) and in vitro systems (White et al. 1985; Sakmann et al., 1985), 
and functionally expressed in Xenopus oocytes for both Torpedo californica and 
calf. Considerable understanding has been gained on the molecular basis of AChR 
function [for recent reviews, see Conti-Ttonconi & Raftery, 1982; Raftery et al., 
1983; Adams, 1981; Taylor et al., 1983; Changeux et al., 1984]. Outstanding 
structural questions include the primary structural locations of the ion channel, 
possible multiple agonist binding sites, and regulatory sites. The complementary 
approaches of site directed mutagenesis, immunochemical mapping, and chemical 
labeling experiments should soon answer these structural questions. Correlation 
of structural data with kinetic data will lead to an understanding of the mecha-
nisms involved in the transduction of a signal mediated by agonist concentration 
into a membrane depolarization. The possible regulation of AChR function by 
other mechanisms, such as phosphorylation which may regulate the rate of ago-
nist induced desensitization of the receptor (Huganir et al., 1986), also remains an 
important area of research. 
The T. californica AChR is a pentameric complex of four homologous sub-
units with apparent Mr 40K (a), SOK (.B), 60K (I), and 65K (o) as determined 
by Laemmli gels (Figure 1) in a stoichiometry of 2:1:1:1, respectively {Raftery et 
al., 1980). The exposure of the receptor to both the extracellular and cytoplas-
mic sides of the membrane has been demonstrated by labeling (Hartig & Raftery, 
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FIGURE 1: Resolution of the AChR subunits on a Na+DodS04-polyacrylamide 







1977), proteolytic, and immunological studies(Karlin et al., 1978; Strader et al., 
1979; Tarrab-Hazdai et al., 1978). Definitive evidence for the transmembrane na-
ture of all four subunits of the AChR resulted from tryptic proteolysis on both 
the intracellular and extracellular sides of sealed vesicles (Strader & Raftery, 1980; 
Conti-Tronconiet al., 1982a). Although the exposure of AChR to the lipid bilayer 
had been investigated using photoactivated probes which partition predominantly 
into the lipid bilayer(Sator et al., 1979; Gonzalez-Ros et al., 1979; Tarrab-Hazdai 
et al., 1980), the results were contradictory. In this thesis, the exposure of all four 
subunits of the AChR to the hydrocarbon core of the lipid bilayer has been conclu-
sively demonstrated using [3 H]adamantanediazirine (Middlemas & Raftery, 1983). 
This result agrees with the sequence data of Noda et al. (1982, 1983a, 1983b) 
which shows that all four subunits contain homologous putative membrane span-
ning regions. In this thesis, it has also been demonstrated that all four subunits 
interact with the cholesterol photoaffinity reagent, [3 H]cholesteryl diazoacetate. 
As the reactive group of this probe is situated near the the aqueous-lipid inter-
face, this result also suggests that the subunits interact with the membrane in a 
symmetric fashion. 
Noda et al. (1983b) proposed four membrane-spanning regions for each sub-
unit based on the conserved sequence of hydrophobic regions in the subunits. It has 
been generally assumed that since the subunits are homologous, the basic folding 
of each subunit will be similar. Models with four transmembrane regions were also 
proposed by Claudio et al. (1983) and Devillers-Thiery et al. (1983). Conversely, 
Guy (1983) and Finer-Moore & Stroud (1984) have proposed a model based on 
the sequence data with the four hydrophobic transmembrane segments and an 
additional amphipathic segment, which was proposed to compose part of the ion 
channel. As the amino terminal region of each subunit is likely to be extracellular, 
each model makes a different prediction for the location of the carboxyl termi-
nal. Ratnam & Lindstrom (1986), using antibodies raised against the carboxyl 
terminal region, have concluded the carboxyl terminal region is intracellular. The 
result is consistent with the model proposing five transmembrane segments, one 
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of which is amphipathic. However, Ratnam et al. (1986) now have additional im-
munochemical data which suggest the two putative membrane-spanning segments 
most proximal to the carboxyl terminus are intracellular domains. One of these 
regions was proposed to be the amphipathic helix contributing to the ion channel. 
As these results confirm that the transmembrane topology of a membrane protein 
is difficult to predict based on hydropathy profiles derived from primary amino 
acid sequence data, these results reaffirm the need for experimental mapping of 
the lipid and aqueous exposed domains of membrane proteins to generate better 
understanding of how the primary structure of a membrane protein codes for the 
tertiary stucture. 
The affinity labels that react with the AChR after reduction of a disulfide 
bond, BrACh (Damle et al., 1978; Moore and Raftery, 1979) and MBTA (Damle 
and Karlin, 1978), have demonstrated the existence of binding sites on the 40K 
subunits for agonists and antagonists. These binding sites undergo an agonist-
induced increase in the binding affinity of the site which is correlated with physio-
logical desensitization. Noda et al. (1982; 1983a,b) postulated the disulfide bond 
was composed of cysteine residues 128 and 142, as these residues are conserved 
in all four subunits and are located in the amino terminal region of the subunits. 
The expression of functional AChR in Xenopus oocytes by injection of mRNA 
synthesized in an in vitro phage SP6 RNA polymerase transcription system from 
the cDNAs has allowed site-directed mutagenesis studies and subunit hybrid re-
ceptor studies (AChR composed of subunits from different species) (Mishina et 
al., 1985; White et al., 1985). After changes of cysteine to serine for each of these 
four cysteine residues independently, it was postulated that cysteine residues 128 
and 142 compose a disulfide bond and cysteine residues 192 and 193 compose a 
disulfide bond. This was based on the finding that the a-bungarotoxin binding 
activity was virtually eliminated and the amount of AChR expressed was substan-
tially decreased in the mutants with either cysteine residue 128 or 142 .changed to 
serine. On the other hand, the binding of a-bungarotoxin was nearly normal in 
the mutants with the change of cysteine residue 192 or 193. As they also found 
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that the changes of either cysteine residues 192 or 193 results in a complete loss 
of acetylcholine sensitivity, it was suggested that cysteine residues 192 and 193 
form part of the agonist binding site. It was noted that cysteine residues 192 and 
193 are both unique to the 40K subunit, whereas 128 and 142 are conserved in 
all four subunits. Kao et al. (1984) found that the affinity reagent, MBTA, labels 
cysteine residue 192 and possibly 193. It has now been demonstrated that cysteine 
residues 192 and 193 compose a disulfide bond near the agonist binding site which 
is labeled by MBTA (Kao & Karlin, 1986). 
As the AChR is a pen tamer of homologous subunits, the existence of multiple 
classes of binding sites for agonists is certainly a possibility. Evidence of other 
distinct binding sites, with a relatively low affinity, for agonists has been acquired 
(Dunn and Raftery, 1982; Conti-Tronconi et al., 1982b; Dunn et al., 1983). The 
existence of these sites was discovered by monitoring fluorescence changes of a 
covalently bound probe. Stopped-flow kinetic studies of this agonist-induced con-
formational change reveal its time dependence is similar to channel opening. As 
agonist binding to these sites is unaffected by desensitization or covalent labeling 
with BrACh, these sites are not those on the 40k subunit which can be labeled 
by the affinity techniques. It was also noted that the half-maximal response in 
electrophysiological experiments is also in a relatively low-affinity range (Adams, 
1981). It has been postulated that the low affinity sites correspond to the physi-
ologically relevant sites for channel opening and that desensitization and channel 
opening are parallel processes (Dunn & Raftery, 1982; Raftery et al., 1983) . In this 
thesis, studies with an affinity cleavage reagent provide evidence for the existence 
of a low affinity binding site on the 60K subunit. 
The expression of a hybrid AChR by White et al. (1985) containing the a:, /3, 
and 1 subunits from T. californica and the 6 subunit from calf in a Xenopus oocyte 
expression system resulted in functional receptors that have a 3-4-fold greater 
response to acetylcholine than does the T. californica receptor. Sakmann et al. 
(1985) in a similar experiment demonstrated the gating behavior of the a hybrid 
containing the a:, /3, and 1 subunits from T. californica and the 6 subunit from 
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calf is different, but that the channel conductance is similar, using single-channel 
current measurements. Mishina et al. (1986) found that the conductance and 
gating properties are different between fetal and adult calf AChR. This difference 
is dependent on the fetal E subunit being replaced by the adult / subunit. It 
is possible that the / and 8 subunits have functional roles in gating of the ion 
channel. 
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Chapter 1 
Exposure of the Acetylcholine Receptor to the Lipid Bilayer 
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INTRODUCTION 
The nicotinic AChR isolated from the electric organ of T. californica is a 
pentameric complex of four homologous subunits with apparent molecular weights 
of 40K, SOK, 60K, and 6SK in a stoichiometry of 2:1:1:1 (Raftery et al., 1980). 
As the AChR is an ion channel, studies directed at the transmembrane nature 
of the subunits are crucial to our understanding of communication through the 
nicotinic synapse. A unique opportunity to investigate the transmembrane nature 
of an ion channel is afforded by the availability of membrane fragments greatly 
enriched in AChR prepared from Torpedo electric organ [for a recent review, see 
Conti-Tronconi & Raftery, 1982]. 
Several experimental approaches have shown that T. californica AChR is a 
transmembrane protein. Extracellular exposure of AChR was demonstrated using 
anti-AChR antibodies conjugated with ferritin visualized by electron microscopy 
(Karlin et al., 1978). In other electron microscopic studies, antigenic determi-
nants were revealed on both sides of the electroplax membrane in T. californica 
(Tarrab-Hazdais et al., 1978; Strader et al., 1979). Exposure of the 40K, SOK, 
and 60K subunits to the aqueous phase was shown by labeling with 125 I using lac-
toperoxidase (Hartig and Raftery, 1977). Although trypsin added to the outside 
of T. marmorata vesicles resulted in no degradation, after sonication, the three 
subunits present in the preparation were degraded. This suggests intracellular 
exposure of the subunits (Wennogle and Changeux, 1980). Definitive evidence 
for the transmembrane nature of all four subunits of T. californica AChR was 
obtained by proteolysis with trypsin (Strader and Raftery, 1980). Trypsin added 
both externally and internally to sealed vesicles, 9S% of which had their synaptic 
surface facing the external medium, resulted in proteolysis of all four subunits. 
Although both external and internal exposure to trypsin cause significant subunit 
degradation, neither alter agonist induced flux properties (Conti-Tronconi et al., 
1982). This lends credence to the conclusion that proteolysis occurs at tryptic 
cleavage sites exposed on both sides of the membrane rather than an artifactual 
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exposure of cleavage sites caused by degradation and subsequent perturbation of 
the AChR-lipid complex. 
Although it is evident that all of the subunits span the post-synaptic mem-
brane, whether all four subunits are exposed to the lipid bilayer has not been estab-
lished. Previous experiments using photoactivated probes which partition into the 
lipid bilayer yielded conflicting results. 5-[125 I]iodonapthyl-1-azide labeled exclu-
sively the 40K subunit (Tarrab-Hazdai et al., 1980) while [3 H]pyrenesulfonyl azide 
labeled polypeptides of 48K and 55K (Sator et al., 1979; Gonzalez-Ros et al., 1979). 
In this chapter, we have investigated the exposure of AChR to the hydrocarbon 
core of the lipid bilayer using the photoactivated probe [3 H]adamantanediazirine 






which generates a carbene upon photolysis, is probably a more effective hydropho-
bic probe than the alternative probes which generate nitrenes (Bayley & Knowles, 
1980). This hydrophobic probe has previously been shown to efficiently label both 
unsaturated and saturated membrane lipids (Bayley & Knowles, 1978a,b) and has 
subsequently been used to selectively label regions of integral membrane proteins 
exposed to the lipid bilayer (Goldman et al., 1979; Bayle & Knowles, 1980; Farley 
et al., 1979; Kaufman & Strominger, 1979). 
MATERIALS AND METHODS 
Preparation of Membrane Fragments. Membrane fragments enriched in AChR 
were prepared from electric organs from T. californica as described by Elliott et 
al. (1980) and were further purified by alkali extraction, which removes peripheral 
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proteins (Neubig et al., 1979; Elliott et al., 1979). The membranes were finally 
suspended in Torpedo Ringer's solution adjusted to pH 7.4 (250 mM NaCl, 5 mM 
KCl, 20 mM Hepes, 0.02% NaN3, and 2 mM MgCl2). Protein concentrations were 
determined by the method of Lowry et al. (1951). The concentrations of a-BgTx 
sites were determined by the method of Schmidt and Raftery (1973) using [125 I]a-
BgTx obtained from New England Nuclear and calibrated by the procedures of 
Blanchard et al. (1979). The specific activity of the preparations varied between 
1.4 and 3.6 nmol of a-BgTx binding sites mg-1 of protein. All tritium samples 
were counted on a Beckman LS 233 counter following addition of 10 ml of Aqua.sol 
2 (New England Nuclear). 
Conversion of the primarily 13S dimeric form of AChR obtained in the mem-
brane preparations to the 9S monomeric form was accomplished using a modifi-
cation of the method of Conti-Tronconi et al. (1981). Reduction and alkylation 
were performed at 4°C in Torpedo Ringer's solution adjusted to pH 8.5. 0.1 Vol-
ume of dithiothreiotol freshly dissolved in the same buffer was added to membrane 
fragments suspended at a concentration of 2 mg protein m1- 1. The suspension 
was stirred for 1 hr, followed by the addition of 0.1 volume of 100 mM iodoac-
etamide freshly dissolved in Ringer's adjusted to pH 8.5. After stirring for 5 min, 
the suspension was diluted with Ringer's adjusted to pH 7.4 and centrifuged at 
40,000 g for 45 min. After centrifugation, the membranes were resuspended in 
Ringer's solution (pH 7.4). The extent of the reaction was determined by sucrose 
gradient centrifugation of solubilized receptors trace labeled with [125I]a-BgTx, 
which separates monomers from dimers. Typically, 99% of a-BgTx binding activ-
ity sediments in the 9S monomeric form after reduction and alkylation. 
Synthesis of Adamantanediazirine and f H}Adamantanediazirine. [3H]Ada-
mantanediazirine (596 mCi mmo1-1) was synthesized and purified by the method 
of Bayley and Knowles (1980). [3H]Adamantanone ethylene ketal needed for 
the synthesis was prepared by Amersham Corporation from bromoadamantanone 
ethylene ketal, which we provided. TLC was performed on silica gel 60 on plastic 
support developed with petroleum ether (b.p. 35-60°C): diethyl ether (3:1), which 
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were then sliced and counted. The UV-visible spectra were recorded on a Cary 
118 spectrophotometer. The time course of photolysis for adamantanediazirine in 
AChR enriched membrane vesicles was monitored by the absorbance at 372 nm. 
f H}Adamantanediazirine Binding to Membrane Fragments. [3 H]Adaman-
tanediazirine (9mCi mmol- 1) in ethanol was added to membrane fragments in 
Torpedo Ringer's solution at room temperature under dim light. In each of 4 
samples, the final concentrations of [3 H]adamantanediazirine, membrane protein, 
and ethanol were 25 µM, 1 mg m1- 1 , and 1 % , respectively. After 1 hr incuba-
tion in the dark, the radioactivity in a portion of each sample was determined. 
The samples were then centrifuged at 147,000 g for 45 min. The supernatant 
and the resuspended pellets were then counted to determine the radioactivity of 
each. No correction was made for trapped volume of free solution in the pellet. 
The radioactivity in the pellet was interpreted as the amount of ligand bound to 
membrane fragments. Counting efficiency was accounted for using [3 H]H2 0 as 
an internal standard. This centrifugation method was also used to determine the 
fraction of [3 H]adamantanediazirine bound to the membrane vesicles at various 
concentrations of AChR enriched vesicles. 
Labeling of Membrane Fragments. All photolabeling experiments were car-
ried out in Torpedo Ringer's solution with constant stirring at room tempera-
ture. [3 H]Adamantanediazirine (596 mCi mmol- 1) in ethanol was added to mem-
brane fragments in a quartz cuvette under dim light. The final concentrations 
of [3 H]adamantanediazirine, membrane protein, and ethanol were 33 µM, 1 mg 
m1- 1, and 1%, respectively. The sample was incubated in the dark for 30 min and 
then irradiated for 30 min using a UVSL-25 lamp (Ultraviolet Products) set on the 
long wavelength setting. After photolysis, the membrane fragments were diluted 
28 fold with 1 % BSA in Torpedo Ringer's solution. Following a 15-min incubation, 
a portion was removed to determine the radioactivity and the sample was then 
centrifuged for 15 min at 252,000 g. The BSA wash of the pellet WR$ repeated, 
followed by 2 washes in buffer without BSA. Portions of both the supernatant and 
pellet were taken for determination of the radioactivity. The radioactivity remain-
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ing in the pellet was considered to represent the covalent attachment of radiolabel 
to membrane fragments. 
Variations in labeling conditions. Both monomeric and dimeric forms of the 
AChR in membrane fragments were photolabeled as described above with and 
without reduced gluatathione in the buffer. All other experiments were carried 
out on membrane preparations that were not reduced and alkylated. 
Membrane fragments desensitized with 10 µM carbamylcholine chloride and 
4 mM CaC12 were photolabeled as already described. That the membranes were 
desensitized was shown by the associated inhibition of the time course of a-BgTx-
receptor complex formation using the procedure of Lee et al. (1977). A control 
lacking carbamylcholine was simultaneously labeled. Membrane fragments satu-
rated by addition of a 2 fold excess of a-BgTx were photolabeled as previously 
described. Determination of the concentration of a-BgTx sites verified that the 
sites were saturated. A control lacking a-BgTx was photolabeled simultaneously. 
Prelabeling was carried out by the addition of 0.007 volumes adamantanedi-
azirine in ethanol under dim light to membrane fragments (lmg m1- 1) resulting in 
a concentration of 100 µM. The sample was incubated in the dark with stirring for 
60 min, after which it was irradiated for 30 min with stirrring. Then 0.003 volumes 
of [3 H]adamantanediazirine in ethanol were added under dim light resulting in a 
concentration of 18 µM. After 30 min of incubation in the dark with stirring, the 
sample was irradiated for 30 min with stirring. The BSA extraction was carried 
out as already described. A control with ethanol added in the first step, followed 
by addition of [3 H]adamantanediazirine, was simultaneously labeled. 
Gel Electrophoresis. NaDodS0 4-polyacrylamide gel electrophoresis was per-
formed using the system of Laemmli (1970) with 8.75% (wt/vol) acrylamide cylin-
drical gels (0.5 x 10 cm). After electrophoresis, gels were stained with 0.5% 
Coomassie Blue R-250 in 10% acetic acid/25% propanol/65% water and destained 
in the same solvent without the dye. Gels were then sliced with a Hoeffer Scientific 
Instruments gel slicer. Each slice was sealed in a glass scintillation vial with 0.5 ml 
H2 0 2 and incubated at 60°C for 5 hr followed by determination of radioactivity. 
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RESULTS 
[3 H]Adamantanediazirine was synthesized according to Bayley & Knowles 
(1980). All of the radioactivity in the purified [3 H]adamantanediazirine prepa-
ration comigrated with the cold diazirine on TLC (Figure 1). The UV-visible 
spectrum of the tritiated diazirine was identical to adamantanediazirine (Figure 
2) . The time course of photolysis for adamantanediazirine in AChR enriched 
membrane vesicles is shown in Figure 3. 
The distribution of [3 H]adamantanediazirine between the aqueous phase and 
AChR enriched membranes was determined by incubation of the hydrophobic 
probe with membrane fragments, which were then pelleted by centrifugation. The 
partition coefficient for the diazirine between the aqueous buffer and the membrane 
fragments defined as (mol ligand bound/mg protein)/ (mol free ligand/ µl external 
solution) is 1320. Assuming a density for the hydrocarbon core of 0. 75 g/ml and 
using published values for the protein-lipid ratio in AChR enriched membrane 
fragments (Schiebler & Hucho, 1978; Popot et al. 1978), the ratio of diazirine in 
the hydrocarbon core to that in the surrounding aqueous phase is - 2000. If the 
binding of adamantanediazirine is a simple partitioning, then the partitioning of 
the probe between the aqueous phase and the membranes can be described by 
b Pc 
(b + !) (1000 +Pc) 
where bis the bound reagent per unit volume of suspension, f is the free reagent per 
unit volume of suspension, c is the concentration of protein, and P is the partition 
coefficient. The fraction of [3 H]adamantanediazirine bound at various membrane 
vesicle concentrations is consistent with a simple partitioning (Figure 4). These 
results indicate [3 H]adamantanediazirine partitions into the lipid bilayer where it 
can interact with regions of membrane proteins in contact with the lipids (Figure 
5). 
Irradiation of AChR enriched membrane fragments equilibrated with [3 H]ada-
mantanediazirine resulted in labeling of all four subunits (Figure 6 ) . In addition, 
-18-
FIGURE 1: TLC of [3 H]adamantanediazirine on silica gel 60 developed with 
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FIGURE 3: The time course of photolysis of adamantanediazirine in AChR en-
riched membrane vesicles. 
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FIGURE 4: The fraction of [3 H]adamantanediazirine bound at various membrane 
vesicle concentrations is plotted. The data were fit to the equation described in 
the text for a simple partitioning of a hydrophobic reagent between an aqueous 
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FIGURE 5: A model depicting the partitioning of [3 H]adamantanediazirine into 
the hydrocarbon core of the lipid bilayer. 
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FIGURE 6: Polyacrylamide gel electrophoresis scan of AChR enriched membrane 






there was a peak of radioactivity corresponding to a polypeptide of Mr 30K, which 
corresponds to unidentified proteins that are always contained in the AChR en-
riched vesicles preparation. There was also incorporation of radiolabel into a 43K 
and 90K dalton protein in experiments on membrane preparations which were 
not alkali extracted to remove these proteins (Figure 7). The 90K dalton pro-
tein may be a subunit of the Na+-K+ ATPase, which is an integral membrane 
protein. However, the proteins with Mr of 43K are thought to be peripheral 
membrane proteins. As [3 H]adamantanediazirine labels one or more of the 43K 
dalton proteins, it is likely that they are associated with the lipid bilayer. Al-
ternatively, membrane associated proteins bound by integral membrane proteins, 
but that do not interact with the lipid bilayer, would presumably not be labeled 
by [3 H]adamantanediazirine. The large peak of radioactivity which comigrates 
with the dye front corresponds to radiolabeled lipids. In all of the experiments, 
between 30 and 40% of the radiolabel was incorporated covalently into membrane 
fragments upon photolysis (Figure 8). Of that, about 50% was incorporated into 
protein components with the remainder covalently attached to membrane lipids. 
The ratio of label incorporation into the subunits is about 2:1:1:1, although 
the 40K is labeled more than expected by the stoichiometry of the subunits. The 
greater reactivity of the 40K subunit could be due to either its amino acid com-
position or a greater surface exposure. Dynamic interactions with other receptors 
or membrane proteins could also affect the time-averaged surface exposure of a 
particular subunit to the lipid bilayer. 
The effect of agonist, which causes a conformational change which has been 
correlated with physiological desensitization (Weber et al., 1975; Weiland et al., 
1976; Lee et al., 1977), on the photoincorporation of radiolabel into the subunits 
was investigated. Desensitization of the AChR by inclusion of 10 µM carbamyl-
choline in the buffer did not alter the incorporation of radiolabel into the subunits. 
Likewise, saturation of AChR with a-BgTx did not affect the radiolabel distribu-
tion among the subunits. Photolabeling of both the 9S monomer and the 138 
dimer in membrane fragments also resulted in indistinguishable distributions of 
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FIGURE 7: Polyacrylamide gel electrophoresis scan of AChR enriched membrane 
vesicles which were not alkali extracted (extraction removes the 43K and 90K 















FIGURE 8: Extraction of non-covalently bound [3 H]adamantanediazirine from 
AChR enriched vesicles after photolysis. Extractions 1 and 2 were with 1 % BSA 















radiolabel among the subunits. 
The inclusion of 20 mM reduced glutathione in the buffer did not alter the 
ratio of photoincorporation of radiolabel among the subunits, although the total 
incorporation of radiolabel into the subunits decreased by about 10% (Figure 
9). As glutathione is an aqueous soluble scavenger of carbenes, this experiment 
confirms that the labeling occurs in regions of AChR exposed to the lipid bilayer. 
The possibility that photolabeling by [3 H]adamantanediazirine was occurring 
at high-affinity saturable binding sites was investigated. The membrane fragments 
were labeled with 100 µM adamantanediazirine and then labeled with 18 µM 
[3 H]adamantanediazirine. This prelabeling did not alter the the total covalent 
incorporation of radiolabel into the membrane fragments or the incorporation of 
radiolabel into the AChR subunits, which indicates that the diazirine interacts 
non-specifically with AChR after partitioning into the lipid bilayer. 
DISCUSSION 
The exposure of AChR subunits to the lipid bilayer has previously been in-
vestigated using hydrophobic photolabile probes, yielding conflicting results. Irra-
diation of 5-[125I]iodonapthyl-l-azide equilibrated with AChR enriched membrane 
fragments isolated from T. californica exclusively labeled the 40K subunit (Tarrab-
Hazdai et al., 1980). A similar reagent, [3 H]pyrenesulfonyl azide labeled polypep-
tides of 48K and 55K daltons in membranes (Sator et al., 1979; Gonzalez-Ros, 
1979). This variability in labeling may have arisen from preferential reactivity of 
different nitrenes with particular subunits. 
[3 H]Adamantanediazirine, which generates a carbene upon irradition, was 
proposed as an alternative to aryl nitrene probes by Bayley and Knowles (1978a,b). 
After finding that [3 H]adamantanediazirine labeled both unsaturated and satu-
rated membrane lipids more efficiently than aryl nitrenes (Bayley & Knowles,1978a, 
1978b), the probe was subsequently used to selectively label regions of integral 
membrane proteins in contact with the hydrocarbon core of the lipid bilayer (Gold-
-36-
FIGURE 9: Polyacrylamide gel electrophoresis scan of AChR enriched membrane 
vesicles labeled with [3 H]adamantanediazirine in the presence of 20mM reduced 
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man et al., 1979; Bayle & Knowles, 1980; Farley et al., 1979; Kaufman & Stro-
minger, 1979). Our results also indicate that [3 H]adamantylidene may be a more 
effective hydrophobic probe than aryl nitrene probes. 
AChR is a pen tamer of homologous subunits (Raftery et al. 1980), all of 
which span the membrane (Strader & Raftery, 1980; Conti-Tronconi et al, 1982). 
Recently elucidated sequences of cDNAs for these subunits indicate that there 
are four hydrophobic regions conserved in each subunit (Noda et al., 1982, 1983a, 
1983b; Sumikawa et al., 1982; Claudio et al., 1983; Devillers-Thiery et al., 1983). 
We have demonstrated experimentally that all four subunits are exposed to the 
hydrocarbon core of the lipid bilayer. 
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Chapter 2 
Identification of the Subunits of Acetylcholine Receptor 
that Interact with a Cholesterol Photoaffinity Probe 
-42-
INTRODUCTION 
The nicotinic AChR is an integral membrane protein which transduces a 
signal mediated by ACh into a membrane depolarization. This depolarization 
is the result of a transient current caused by the opening of an ion channel [for 
recent review, see Adams (1981)]. A unique opportunity to correlate the molecular 
structure of a gated ion channel with its functional properties is afforded by the 
availability of membrane vesicles greatly enriched in AChR from Torpedo electric 
organ [for recent reviews, see Conti-Tronconi & Raftery (1982) and Raftery et al. 
(1983)]. 
The AChR isolated from T. californica is a pentameric complex of homolo-
gous subunits with apparent Mr of 40K, SOK, 60K, and 6SK in a stoichiometry of 
2:1:1:1 (Raftery et al., 1980). Several experimental approaches have shown that 
T. californica AChR is a transmembrane protein. Extracellular exposure of AChR 
was demonstrated using anti-AChR antibodies conjugated with ferritin visualized 
by electron microscopy (Karlin et al., 1978). In other electron microscopic studies, 
antigenic determinants were revealed on both sides of the electroplax membrane 
(Strader et al., 1979, Tarrab-Hazdai et al., 1978). Exposure of the 40K, SOK, and 
60K subunits to the aqueous phase was shown by labeling with 125 I using lactoper-
oxidase (Hartig & Raftery, 1977). Although trypsin added to the outside of T. 
marmorata vesicles resulted in no degradation, after sonication, the three subunits 
present in the preparation were degraded, suggesting their intracellular exposure 
(Wennogle & Changeux, 1980). Definitive evidence for the transmembrane na-
ture of all four subunits ~f T. californica AChR was obtained by proteolysis with 
trypsin (Strader & Raftery, 1980). Trypsin added both externally and internally 
to sealed vesicles, 9S% of which had their synaptic surface facing the external 
medium, resulted in proteolysis of all four subunits. Although both external and 
internal exposure to trypsin cause significant subunit degradation, neither alter 
agonist induced flux properties (Conti-Tronconi et al., 1982). This lends credence 
to the conclusion that proteolysis occurs at tryptic cleavage sites exposed on both 
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sides of the membrane rather than an artifactual exposure of cleavage sites caused 
by degradation and subsequent perturbation of the AChR-lipid complex. 
The exposure of AChR to the lipid bilayer has been studied using photoac-
tivated probes which partition predominantly into the lipid bilayer. 5-[125I]iodo-
napthyl-1-azide labeled exclusively the 40K subunit (Tarrab-Hazdai et al., 1980) 
while [3 H]pyrenesulfonyl azide labeled polypeptides of 48K and 55K (Sator et al., 
1979; Gonzalez-Ros et al., 1979). This difference in labeling pattern may be due to 
different reactivity of nitrenes. Using [3 H]adamantanediazirine, all four subunits of 
the AChR were labeled, demonstrating exposure of all four subunits to the hydro-
carbon core of the lipid bilayer (Middlemas & Raftery, 1983). [3 H]Adamantane-
diazirine, which generates a carbene upon photolysis, is probably a more effective 
hydrophobic probe than the alternative probes which generate nitrenes (Bayley & 
Knowles, 1980). This result agrees with the sequence data of Noda et al. (1982, 
1983a, 1983b) which show that all four subunits contain putative membrane span-
ing regions. 
It is probable that AChR is a pseudosymmetric complex of homologous sub-
units, all of which interact with the lipid bilayer in a similar manner. The role 
of lipids in the function and structure of the AChR remains an important area 
of research. There is evidence that cholesterol is important to AChR function. 
In reconstitution experiments, inclusion of cholesterol was needed for protection 
of agonist-induced change in affinity of binding sites (desensitization)( Criado et 
al., 1982) and protection of agonist-induced 86Rb+ flux (Dalziel et al., 1980). Us-
ing a spin labeled steroid probe, an immobilized component was revealed by ESR 
spectra which suggests AChR interacts with neutral lipids (Marsh & Barrantes, 
1978). 
Although cholesterol may be important to AChR function, it is not clear 
whether this is due to its effect on membrane properties or a specific interaction 
with AChR. In this communication, we have used the cholesterol photoaffinity 
probe, cholesteryl diazoacetate, to resolve whether or not cholesterol interacts 




photolysis. Cholesteryl diazoacetate incorporates into lipid bilayers analogously 
to cholesterol and is therefore a direct tool to study the interaction of choles-
terol with both lipids and membrane proteins. It is immobilized in bilayers like 
cholesterol and upon irradiation incorporates into the choline head group of phos-
phatidylcholine (Keilbaugh & Thornton 1983a,b). This result supports the notion 
that the carbene is generated near the lipid-water interface. 
MATERIALS AND METHODS 
1H NMR spectra were recorded on a Varian Associates EM 390 (90 MHz) 
spectrometer using tetramethylsilane as the internal reference. Chemical shifts are 
reported in ppm downfield from the reference. UV-visible spectra were recorded on 
a Cary model 118 spectrophotometer. Fourier transform infrared (FT-IR) spectra 
were recorded on a Mattson Instruments Sirius 100 FT-IR equipped with Starlab 
minicomputer data station and high-resolution graphics terminals under a positive 
nitrogen purge. 
Preparation of Membrane Fragments. Membrane fragments enriched in AChR 
were prepared from electric organs from T. cal if ornica as described by Elliot et al. 
(1980) and were further purified by alkali extraction (Neubig et al., 1979; Elliott et 
al., 1979). The membranes were finally suspended in Ca2+-free Torpedo Ringer's 
solution adjusted to pH 7.4 (250 mM NaCl, 5 mM KCl, 20 mM HEPES, 0.02% 
NaN3 , and 2 mM MgC12). Protein concentration was determined by the method 
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of Lowry et al. (1951). The concentration of a:-BgTx sites was determined by 
the method of Schmidt & Raftery (1973) using [125I]a:-BgTx obtained from New 
England Nuclear and calibrated by the procedures of Blanchard et al. (1979). The 
specific activities of the preparations varied between 2.0 and 3. 7 nmol of a:-BgTx 
binding sites mg- 1 of protein. All tritium samples were counted on a Beckman 
LS 233 counter following addition of 10 ml Aquasol 2 (New England Nuclear). 
Synthesis and Purification off H}Cholesteryl Diazoacetate. Cholesteryl dia-
zoacetate was synthesized and purified by the method of Keilbough & Thornton 
(1983a). A similar method was used to synthesize [3 H]cholesteryl diazoacetate 
from [7-3 H]cholesterol (12 Ci mmol- 1) purchased from ICN Pharmaceuticals, Inc. 
2.8 µmol of cholesterol was added to 5.3 mCi of [7-3 H]cholesterol in benzene (1 mCi 
ml- 1) . The solvent was removed under reduced pressure at 22 °C. The cholesterol 
was dissolved in 14 µl of CH2Cl2:THF (1:1) containing 5 µmol of redistilled TEA 
on ice. 5.2 µmol of glyoxylic acid chloride p-toluene sulfonyl hydrazone, prepared 
by the method of Blankley et al. (1969), was added in 17 µl of CH2 Cl2 cooled 
to 0°C. After 30 min in the dark on ice, 5 µmol of TEA in 5 µl of CH2Cl2 was 
added. The solution was brought to 22°C. After 30 min, the solvent was removed 
under reduced pressure at 22 °C. The residue was extracted twice with 100 µl of 
toluene. The extracts were applied to a 0.5 x 4 cm silica gel 60 column (Merck) 
and eluted with toluene. Toluene was removed from the purified diazoacetate un-
der reduced pressure. The diazoacetate was taken up in ethanol for determination 
of the specific activity and introduction into membranes. 
The specific activity of [3 H]cholesteryl diazoacetate was determined by using 
UV absorbance at 247 nm (E247=17,000) and scintillation counting using [3H]H20 
as an internal standard. Plastic-backed silica gel 60 TLC plates (Merck), which 
were eluted with toluene and then sliced and counted, were used to verify the 
purity of the tritiated diazoacetate. The unlabeled diazoacetate was visualized on 
TLC plates with 12 • 
Photolysis of Cholesteryl Diazoacetate. Photolysis was carried out in a quartz 
cuvette with a UVSL-25 lamp (Ultraviolet Products) set on the short wavelength 
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setting. The rate of photolysis of cholesteryl diazoacetate in ethanol and cyclo-
hexane was monitored by the absorbance at 24 7 nm. The rate of photolysis of the 
tritiated diazoacetate incorporated into vesicles enriched in AChR was monitored 
by taking time aliquots for TLC. When eluted with toluene, the diazoacetate mi-
grated near the solvent front while the products of photolysis remained near the 
origin. The TLC plates were then sliced and counted. 
Labeling of Membrane Vesicles. All photolabeling experiments were carried 
out in Ca2+-free Torpedo Ringer's solution with constant stirring at room temper-
ature. [3 H]Cholesteryl diazoacetate in ethanol was added to membrane vesicles 
in a quartz cuvette under dim light. The final concentrations of [3 H]cholesteryl 
diazoacetate, membrane protein, and ethanol were 12 µM, 1 mg m1- 1 , and 1%, 
respectively. The sample was incubated in the dark with stirring for 30 min and 
then the cuvette was flushed with argon. The sample was irradiated for 10 min 
using a UVSL-25 lamp set on the short wavelength setting with constant stirring. 
The membranes were then pelleted by centrifuging for 15 min in an Eppendorf 
centrifuge, after which, the samples were taken up in buffer for gel electrophoresis. 
Membrane vesicles desensitized with 10 µM carbamylcholine chloride and 4 
mM CaCh were photolabeled as described. Desensitization was shown by the 
associated inhibition of the time course of a-BgTx-receptor complex formation 
using the procedure of Lee et al. (1977). 
Extraction of lipids from the protein was accomplished by adding 20 volumes 
of chloroform:methanol (2:1) to 1 volume of photolyzed membranes in a glass 
centrifugation tube. After vortexing, the samples were centrifuged at 12,000 g for 
30 min. The supernatant was removed and the pellet was dissolved in buffer for 
gel electrophoresis. Aliquots of both the supernatant and pellet were taken for 
scintillation counting. Quenching was accounted for using [3 H]H2 0 as an internal 
standard. 
Gel Electrophoresis. NaDodS04-polyacrylamide gel electrophoresis was per-
formed using the system of Laemmli (1970) with 10% acrylamide cylindrical gels 
(0.5x10 cm). After electrophoresis, gels were immediately sliced using a Hoeffer 
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Scientific Instruments gel slicer. Each slice was sealed in a glass scintillation vial 
with 0.5 ml of 30% H20 2 and incubated at 70°C for 5 hr followed by determination 
of radioactivity. Electrophoresis of unlabeled AChR preparations was performed 
simultaneously to determine the mobility of the subunits. These gels were stained 
with 0.5% Coomassie Blue R-250 in 10% acetic acid/25% propanol/65% H20 and 
destained in the same solvent without the dye. 
RESULTS 
Cholesteryl diazoacetate was synthesized and purified by the method of Keil-
bough & Thornton (1983a). IR and NMR spectra and melting point agreed with 
the published values. The maximum absorbance in the UV spectrum is at 247 
nm (Figure 1). The IR spectrum exhibits the characteristic absorption band at 
2100 cm- 1 of a diazo group (Figure 2). Using a similar approach, [3 H]cholesteryl 
diazoacetate with a specific activity of 1.64 Ci/mmol was synthesized and purified 
(11% yield). The mobility on TLC, the UV spectrum, and the rate of photolysis 
of the tritiated compound were identical to that of cholesteryl diazoacetate. In 
both labeled and unlabeled cholesteryl diazoacetate, greater than 99% of the UV 
absorbance at 247 nm disappears upon photolysis (Figure 3). 
In order to ensure complete photolysis, the rate of photolysis was determined 
under various conditions (Figure 4). The half lives of photolysis in ethanol 
and cyclohexane are 4 7 and 76 seconds respectively and in membrane vesicles 
containing 1 mg m1- 1 protein, the half life of photolysis was 49 seconds. It is 
interesting to note that the rate of photolysis is similar in both organic solvent 
and in unilamellar vesicles, although much longer irradiation times are required for 
photolysis in multilamellar vesicles (Keil bough & Thornton, 1983b). It is evident 
that exposure to UV light under these conditions will result in virtually complete 
photolysis of the diazo group in 10 min. 
After incorporation of [3 H]cholesteryl diazoacetate into AChR enriched mem-
brane vesicles, irradiation resulted in covalent labeling of all four subunits (Figure 
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FIGURE 3: The UV spectra of cholesteryl diazoacetate before (a) and after (b) 









FIGURE 4: The time course of photolysis of cholesteryl diazoacetate in ethanol 
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5). The ratio of label migrating at the dye front, which corresponds to both labeled 
lipids and cholesterol, to label incorporated into protein is 75. Since much of the 
carbene will react with water to form cholesterol esters and cholesterol, the ratio 
above does not indicate the ratio of carbene insertion into lipids over proteins. 
The high background radioactivity is presumably caused by tritiated cholesterol 
esters and cholesterol (which migrate with the dye front presumably in detergent 
micelles) and therefore a chloroform:methanol extraction of both labeled lipids 
and cholesterol from the protein prior to electrophoresis was used to reduce this 
background. Although the radioactive lipids were not quantitatively extracted, 
about 70% of the radioactivity was extracted with the chloroform:methanol. The 
stoichiometry of covalent incorporation into the 40K, SOK, 60K, and 65K subunits, 
respectively, was about 4:1:1:2, i.e., a molar ratio of 2:1:1:2 (Figure 6). As all four 
subunits should be precipitated during the extraction in a quantitative manner, 
this ratio is likely to be correct. 
Since there is evidence that cholesterol may be important in desensitization or 
at least essential for protection of desensitization properties of receptor during re-
constitution experiments, the effect of agonist on the interaction of [3 H]cholesteryl 
diazoacetate with AChR was investigated. The probe was incorporated into AChR 
enriched vesicles, which were desensitized by exposure to 10 µM carbamylcholine 
as verified by inhibition of [125I]a-BgTx binding. Irradiation of both desensitized 
and control AChR enriched membrane vesicles resulted in identical distributions 
of label among the four subunits. 
In the above experiments, [3 H]cholesteryl diazoacetate was introduced into 
membranes in small portions of ethanol. An alternative method of introducing 
the probe was used to investigate the possibility of the label distribution being 
affected by the ethanol. The probe was introduced into the cuvette and ethanol 
was removed with a gentle stream of nitrogen. Membrane suspension was then 
introduced and stirred at 22°C for 4 hours. Although complete uptake qf the probe 
from the walls of the cuvette was not possible, all four subunits were labeled after 
irradiation. This indicates that ethanol does not affect the labeling of AChR with 
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FIGURE 5: NaDodS0 4-polyacrylamide gel electrophoresis scan of AChR labeled 
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FIGURE 6: NaDodS0 4-polyacrylamide gel electrophoresis scan of AChR labeled 
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[3 H]cholesteryl diazoacetate. 
DISCUSSION 
ESR experiments with a labeled steroid probe indicated an interaction of 
neutral lipids with AChR (Marsh & Barrantes, 1978). Using an androstanol spin 
labeled probe, the electron spin resonance spectra revealed an immobilized com-
ponent along with the fluid component which is found in aqueous dispersions of 
extracted lipids. A similar result was obtained using stearic acid probes. AChR 
has been shown to incorporate more readily into cholesterol monolayers than 
other lipid monolayers, suggesting that it has an affinity for cholesterol (Popot 
et al., 1978). The photolabeling results presented in this communication us-
ing [3 Hjcholesteryl diazoacetate demonstrate definitively that cholesterol interacts 
with AChR. 
Investigations of the distribution of cholesterol in membranes is possible using 
saponin, filipin and digitonin, which form complexes with cholesterol that can be 
identified by electron microscopy after freeze-fracture (Elias et al., 1978,1979). 
Several groups have found little or no evidence for the presence of cholesterol 
in AChR rich regions of membranes using these probes. However, in one study, 
evidence for the presence of cholesterol in areas of membrane rich in AChR clusters 
was found. In both non-innervated and innervated Xenopus embryonic muscle 
cells, there was virtually no indication of cholesterol complexes in areas rich in 
aggregates of AChR particles (Bridgman & Nakajima, 1981). In Rana cutaneous 
pectoris and sartorious muscles, filipin-sterol complexes were absent from regions 
occupied with AChR aggregates (Nakajima & Bridgman, 1981) and there was 
also an almost complete absence of filipin-sterol complexes in AChR rich regions 
of the electroplax membrane of T. marmorata (Perrelet et al., 1982). However, 
in rat myotubes, areas of membrane rich in AChR clusters reacted _extensively 
with filipin, which indicates the presence of cholesterol (Pumplin & Bloch, 1983). 
Although in the same study, membrane rich in AChR clusters in chick myotubes 
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did not react with saponin or filipin (Pumplin & Bloch, 1983). 
The role which cholesterol plays in AChR function has been investigated. 
Inclusion of cholesterol during reconstitution was found to be essential to protect 
agonist-induced affinity change of cholinergic binding sites (Criado et al., 1982). In 
another study it was reported that cholesterol was necessary for the maintenance 
of agonist induced 86Rb+ flux (Dalziel et al., 1980). Zabrecky & Raftery (1985) 
found the binding affinity of AChR for carbamylcholine increased as the cholesterol 
content of membrane vesicles was reduced. The cholesterol content was reduced by 
fusion of AChR enriched vesicles with phospholipid vesicles of defined composition. 
Although, it is apparent that cholesterol is important to AChR function, it is not 
clear whether this is because of its effect on membrane properties or a specific 
interaction with AChR. 
A recent study, using photoreactive phospholipid probes, found that all four 
subunits of both T. californica and T. marmorata AChR were labeled (Giraudat 
et al., 1985) . The study clearly demonstrated that all four subunits interact with 
charged lipids. Our results, which indicate neutral lipids interact with the AChR, 
are consistent with these findings. 
Cholesteryl diazoacetate is a useful reagent for the study of membrane pro-
teins. It is readily photolyzed and exhibits a low level of Wolff rearrangement 
(Keilbough & Thornton, 1983a). Reasonable yields of incorporation into lipids 
and membrane proteins can be obtained. Since the photo-generated carbene is sit-
uated near the lipid-water interface (Keilbough and Thornton, 1983b), this probe 
has potential as a topographic tool to map membrane protein structure. Using a 
photo-activated lipid probe, which also generates a carbene near the lipid-water 
interface, regions of glycophorin A near the interface have been determined (Ross 
et al., 1982). As cholesteryl diazoacetate incorporates into membrane proteins and 
lipids, it is useful in the study of the interaction of cholesterol with both lipids 
and membrane proteins. 
In this communication, we have demonstrated covalent labeling of AChR 
with [3 H]cholesteryl diazoacetate. Since this probe incorporates into lipid bilayers 
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in a fashion analogous to cholesterol, this result confirms that AChR interacts 
with cholesterol. It is interesting to note that the labeling of AChR with this 
probe is very similar to the labeling with [3 H]adamantanediazirine, a probe which 
labels proteins exposed to the hydrocarbon core of the lipid bilayer (Middlemas & 
Raftery, 1983). As both of these reagents label all of the subunits, it is probable 
that all of the subunits interact with the membrane in a related manner. 
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Chapter 3 
Synthesis of Fluorine-Containing Agonists 
for the Acetylcholine Receptor 
-67-
INTRODUCTION 
19F nuclear magnetic resonance (NMR) spectroscopy has been used for the 
study of enzymes (Raftery et al., 1971). 19 F is well suited for this approach to 
enzymology, as it has a large chemical shift range (500 ppm) as well as very high 
sensitivity (83% of 1 H) [for a review of 19 F NMR spectroscopy, see Emsley et al. 
(1968)]. Another important aspect of fluorine is that it can be substituted for 
a proton in many biological substrates and ligands without significantly altering 
their biological properties. 
Equilibrium binding studies of agonists to the AChR reveal the existence of 
two sites with relatively high affinity (equilibrium dissociation constants in the 
range of 1-lOOnM). Under equlibrium conditions, these binding sites have under-
gone an agonist induced increase in affinity which is correlated with physiological 
desensitization. Although various approaches on a faster time scale have allowed 
estimates of the resting dissociation constant of these sites, a discrepancy exists in 
the results [for a recent review, see Changeux et al., 1984]. Two conformational 
transitions have been observed, a slow one (about 0.01 sec- 1 ) and an intermedi-
ate one (between 2-50 sec- 1). The problem arises that channel activation occurs 
faster than these observed conformational transitions. Recently, evidence for a 
faster conformational change (400-600 sec- 1 , i.e., t.! 1.7-1.2 msec), one that is 
2 
more closely correlated in time to channel opening, has been acquired (Dunn and 
Raftery, 1982). This conformational change is caused by agonist binding to sites 
which are distinct from the previously identified high-affinity binding sites (Conti-
Tronconi et al., 1982; Dunn et al., 1983). The existence of these low-affinity sites, 
with equilibrium dissociation constants between 50µM to lmM for various ago-
nists, was discovered by monitoring fluorescence changes of the covalently bound 
probe, NBD. As agonist binding to these sites is unaffected by desensitization 
or covalent labeling with BrACh (an affinity reagent which specifically labels the 
high-affinity sites), these sites are distinct from the high-affinity sites. 
In order to use NMR spectroscopy to study exchange of a ligand at a binding 
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site, a high concentration of membrane-bound ligand binding sites must be ob-
tained. In addition, a ligand must be available that is readily observed by using 
current NMR spectroscopy instrumentation and the ligand binding parameters 
must be suitable for study of the exchange between free and bound states. These 
conditions can be met with the AChR, as demonstrated by Miller et al. (1979) in 
a study of the binding of choline to the receptor. 
The interaction of agonists with these low-affinity sites may be in a range 
amenable to study by 19F NMR. In this chapter, the syntheses of fluoroacetyl-
choline (I) and p-fluorophenyltrimethylammoniumiodide (PFT) (II) are described. 









It is also demonstrated that both of these compounds are agonists for the AChR. 
MATERIALS AND METHODS 
1 H NMR and 19F NMR spectra were recorded on a Varian Associates XL-
200 (200 MHz) spectrometer or a Bruker WM 500 (500 MHz) spectrometer using 
sodium 3-(trimethylsilyl)propane sulfonate as the internal reference for 1 H NMR 
spectra and trifluoroacetic acid as the internal reference for 19 F NMR spectra. All 
spectra were recorded in [2H]H2 0 or H20. Chemical shifts are reported in ppm 
downfield or upfield (negative values) from the references. 
Sodium fluoroacetate, bromoethanol, and iodomethane were purchased from 
Aldrich. Phthaloyl chloride was the generous gift of Dr. R.E. Ireland. Bro-
moethanol was redistilled before use. Benzene was dried and distilled over sodium. 
N ,N-dimethyl-p-fluoroaniline was purchased from TCI. 22 N a+ was purchased from 
NEN. 
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Synthesis of Fluoroacetyl Chloride. All procedures should be done in a hood, 
as monofiuoroacetyl compounds are toxic. Fluoroacetyl chloride was synthesized 
by the method of Pattison et al. (1956). 5 g Sodium fiuoroacetate was added to 
8.5 ml of phthaloyl chloride. After mixing thoroughly, the mixture was heated 
with vigorous stirring in a fl.ask fitted for distillation. The distillate of boiling 
point 70-71° was collected and was used immediately. The yield was 3.2 g (66%). 
Synthesis of Bromoethyl Fluoroacetate. Bromoethyl fiuoroacetate was synthe-
sized by the method of Blohm (1951). 2.2 g of fiuoroacetyl chloride was added 
to 5.6 ml of bromoethanol in 11 ml of benzene. The solution was refluxed for 1 
hr. The solution was fractionally distilled under reduced pressure. Bromoethyl 
fi.uoroacetate was collected between 115-116 ° at 75 mm. The yield was 2.5 g 
(59%). 
Synthesis of Fluoroacetylcholine Bromide. Fluoroacetylcholine bromide was 
synthesized by the method of Blohm (1951). 1 ml of trimethylamine, which had 
been passed through a KOH tower and then condensed, was added to 2.5 g of 
bromoethyl fluoroacetate in 8.3 ml of benzene. After 48 hr at 22 °, the crystalline 
mass was collected and washed with two 20 ml portions of hot acetone. The 
remaining acetone was removed in vacuo over P205. The yield was 0.85 g (26%). 
The compound melted at 122-124 °, which is in agreement with the literature 
(Blohm, 1951). 1H NMR: S 3.21 (s, 9H); 3.79 (t, 2H); 4.71 (t, 2H); 5.06 (d, 2H, J 
= 46 Hz). 19F NMR: S -49.25 (t, J = 50 Hz). 
Synthesis of p-Fluorophenyltrimethylammonium Iodide. 1 ml of iodomethane 
was added to 1 g of N,N-dimethyl-p-aniline in 4 ml of benzene. After 24 hr, the 
crystalline product was collected on a sintered glass funnel and washed with two 5 
ml portions of benzene. The remaining benzene was removed in vacuo over P 2 0 s. 
The yield was 1.23 g (61%). The m.p. of the white crystals was 226 °. 1H NMR: 
S 3.66 (s, 9H); 7.37 (m, 2H); 7.88 (m, 2H). 19F NMR: S -34.63 (s). 
Preparation of AChR Enriched Membrane Fragments. Membrane fragments 
enriched in AChR were prepared from electric organs from T. californica as de-
scribed by Elliot et al. (1980) and were further purified by alkali extraction (Neu-
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big et al., 1979; Elliott et al., 1979). The membranes were finally suspended in 
Ca2+-free Torpedo Ringer's solution adjusted to pH 7.4 (250 mM NaCl, 5 mM 
KCl, 20 mM HEPES, 0.02% NaN3, and 2 mM MgCl2). Protein concentration was 
determined by the method of Lowry et al. (1951). The concentration of a-BgTx 
sites was determined by the method of Schmidt & Raftery (1973) using [125I]a-
BgTx obtained from New England Nuclear and calibrated by the procedures of 
Blanchard et al. ( 1979). The specific activities of the preparations varied between 
2.0 and 3.7 nmol of a-BgTx binding sites mg-1 of protein. 
22 Na+ Flux Assay. Membrane vesicles were suspended in BSA solution (10 
mg m1- 1 ) and incubated for 15-20 min at 22°. The membrane vesicles were then 
pelleted by centrifugation at 40,000 g. This treatment produces sealed membrane 
vesicles probably by removing free fatty acids which may result from the extrac-
tion at pH 11. The pellets were resuspended in 10 mM 2, 2', 2"-nitriloethanol 
buffer adjusted to pH 7.4 containing 200mM NaCL The membranes were pelleted 
by centrifugation and resuspended in the the same buffer containing 15µCi m1-1 
of 22 Na+ and subjected to two cycles of freeze thaw in order to allow equilibration 
of 22 Na+ inside and outside the vesicles. These vesicles were assayed for carbamyl-
choline, fluoroacetylcholine and PFT induced 22 Na+ flux by the method of Wu & 
Raftery (1979). 
RESULTS 
The synthesis of fluoroacetylcholine bromide is shown in Figure 1. The direct 
distillation of fluoroacetyl chloride from the sodium salt and phthaloyl chloride 
developed by Pattison et al. (1956) is convenient for the synthesis of fluoroacetyl 
esters. Previously, production and purification of the acid from the sodium salt, 
followed by synthesis of the acid chloride was required. This convenient synthesis 
of fluoroacetyl esters should allow the routine introduction of fluorine. labels into 
compounds of biological interest. Although the introduction of trifluoroacetyl 
groups is synthetically easy, the esters of trifluoroacetic acid may not be stable 
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in aqueous conditions. Therefore, the introduction of the monofluoroacetyl group 
may be advantageous. The synthesis of PFT is shown in Figure 2. 
Cation flux assays reveal both fluoroacetylcholine bromide and PFT are ag-
onists for the AChR (Figures 3 and 4). Although Blohm (1951) observed the 
cholinergic symptoms of fluoroacetylcholine bromide were less than acetylcholine 
when administered intravenously to rabbits, the assay was probably monitoring 
parasympathetic effects involving the muscarinic AChR. 
-
The 1 H NMR spectrum of fluoroacetylcholine bromide, which indicates the a 
protons are split by coupling to the fluorine, is shown in Figure 5. The 19F NMR 
spectrum is shown in Figure 6, which also has splitting due to coupling of the a 
protons with fluorine. The 1 Hand 19 F NMR spectra of PFT are shown in Figure 
7 and 8. The fluorine chemical shifts of fluoroacetate and fluoroacetylcholine are 
different, indicating there would not be a problem in identifying a signal from 
fluoroacetylcholine as opposed to its product of hydrolysis (Figures 6 and 9). 
The hydrolysis of a fluoroacetate ester could cause problems in NMR exper-
iments, which can require extensive periods of time for data gathering. However, 
preliminary results indicate that less than 10% of fluoroacetylcholine bromide is 
hydrolyzed at neutral pH and room temperature in 12 hr. On the other hand, 
trifluoroacetylcholine iodide was hydrolyzed rapidly. The principal advantage of 
PFT is it cannot be hydrolyzed by acetylcholine esterase, thus caution does not 
have to be excercised to ensure all of the esterase is blocked by irreversible in-
hibitors. Both agonists may prove useful as acetylcholine analogs for the study 
of the nicotinic AChR using 19 F NMR spectroscopy. In addition, fluoroacetyl-
choline could be useful for the investigation of both the muscarinic AChR and 
acetylcholine esterase. 
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FIGURE 2: The synthesis of PFT. 
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FIGURE 3: Fluoroacetylcholine bromide induced cation efflux. 22 Na+-loaded 
vesicles were assayed for 22 Na+ retained in vesicles as a function of time after 
mixing with agonist by the method of Wu & Raftery (1979). Control (0 µM 
agonist) (x), 100 µM carbamylcholine (•), 200 µM fluoroacetylcholine bromide 



















































































































































FIGURE 4: PFT induced cation efflux. 22 Na+-loaded vesicles were assayed for 
22 Na+ retained in vesicles as a function of time after mixing with agonist by the 
method of Wu & Raftery (1979). Control (0 µM agonist) (x), 100 µM carbamyl-








































































































































FIGURE 6: The 19 F NMR spectrum of fluoroacetylcholine bromide in H2 0. 
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Affinity Cleavage of the Acetylcholine Receptor: 
Evidence for a Low-Affinity Agonist Binding Site 
-93-
INTRODUCTION 
The nicotinic AChR isolated from Torpedo californica is a multisubunit pro-
tein of homologous subunits with apparent Mr of 40K (a), SOK (.B), 60K (I), and 
65K (8) in astoichiometryof2:1:1:1 (Raftery et al., 1980). The receptor is atrans-
membrane complex of five subunits, all of which span the lipid bilayer (Strader 
& Raftery, 1980; Middlemas & Raftery, 1983), that forms an agonist gated ion 
channel [for recent reviews, see Conti-Tronconi & Raftery (1982); Raftery et al. 
(1983); Adams (1981)]. 
Binding sites for both agonists and antagonists have been revealed using the 
cholinergic affinity labels, BrACh (Damle et al., 1978; Moore and Raftery, 1979) 
and MBTA (Damle and Karlin, 1978), which specifically label the 40K subunit af-
ter reduction of a disulfide bond. These binding sites undergo an agonist-induced 
affinity change which is correlated with physiological desensitization. As this 
change increases the affinity of the receptor for agonists, we will refer to the sites on 
the 40K subunits as high-affinity sites. Recently, evidence of other distinct binding 
sites for agonists has been acquired (Dunn and Raftery, 1982; Conti-Tronconi et 
al., 1982; Dunn et al., 1983). The existence of these low-affinity sites was discov-
ered by monitoring the change in fluorescence of a covalently bound probe, which 
is presumably caused by a conformational change of the AChR. This conforma-
tional change occurs on a similar timescale as ion channel opening. Since agonist 
binding to these sites is unaffected by desensitization or covalent labeling with 
BrACh, these sites are not those on the 40K subunit which can be labeled by the 
affinity techniques. An important area of research is determining the physiological 
roles of these multiple binding sites and primary structural locations. 
An approach developed to determine the binding sites of molecules on DNA 
uses affinity cleavage reagents (Schultz et al., 1982; Taylor et al., 1984; Baker & 
Dervan, 1985). Such reagents require linking a DNA cleaving functionality to a 
molecule that binds DNA. After cleavage of the DNA, binding sites are determined 
by cleavage pattern analyses using Maxam-Gilbert sequencing gels. Conversely, 
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an approach allowing specific cleavage for any sequence uses oligodeoxynucleotides 
linked to a cleavage functionality (Dreyer & Dervan, 1985). 
Affinity cleavage of neurotransmitter receptors could provide a complemen-
tary approach to affinity labeling in the determination of the primary structural 
locations of ligand binding sites. The molecular weights of the products of a protein 
cleavage reaction determined by polyacrylamide gel electrophoresis yield direct in-
formation about the possible sites of cleavage. Another advantage of an affinity 
cleavage strategy, in the case of membrane proteins, is the relative ease of purifi-
cation of large polypeptides. Affinity labeling usually requires the generation of 
small hydrophobic peptides, which can be difficult to purify, for the determination 
of the primary structural location of labeling. In addition, the subsequent Edman 
degradations for amino acid sequence analysis often proceed in better yields with 
larger polypeptides. 
In this communication, we report the synthesis of the affinity cleavage reagent, 
p-thiocyanophenyltrimethyl ammonium iodide (TPMA) (I) and its specific cleav-
age of a peptide bond near an agonist binding site in the AChR. This reagent, 
I 
which is an agonist for the AChR, cleaves at the amino peptide bond of cysteine 
residues. The mechanism of cleavage is expected to be similar to that of NTCB, 
a general reagent for cleavage of the amino peptide bond of cysteine residues in 
proteins (Vanaman & Stark, 1970; Degani et al., 1970). 
MATERIALS AND METHODS 
1 H NMR spectra were recorded on a Bruker WM 500 (500 MHz) spectrometer 
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using sodium 3-( trimethylsilyl)propane sulfonate as the internal reference for 1 H 
NMR spectra. Chemical shifts are reported in ppm downfield from the reference. 
UV-visible spectra were recorded on a Cary model 118 spectrophotometer. Fourier 
transform infrared (FT-IR) spectra were recorded on a Mattson Instruments Sirius 
100 FT-IR equipped with Starlab minicomputer data station and high resolution 
graphics terminals under a positive nitrogen purge. Benzene was dried and distilled 
over sodium. 
Preparation of Membrane Fragments. Membrane fragments enriched in AChR 
were prepared from electric organs from T. cal if ornica as described by Elliott et al. 
(1980) and were further purified by alkali extraction (Neubig et al., 1979; Elliott 
et al., 1979). The membranes were then suspended in 10 mM HEPES buffer 
containing 10 mM iodoacetamide, 35 mM NaN03 , and 0.02% NaN3 adjusted to 
pH 8.0. After 15 minutes at 22°, the membranes were diluted with 75 volumes 
of H20 and centrifuged at 40,000 g for 50 minutes. The membrane pellets were 
finally suspended in 10 mM HEPES buffer containing 35 mM NaN03 and 0.02% 
NaN3 adjusted to pH 7.4. Protein concentration was determined by the method 
of Lowry et al. (1951). The concentration of a-BgTx sites was determined by 
the method of Schmidt & Raftery (1973) using [125I]a-BgTx obtained from New 
England Nuclear and calibrated by the procedures of Blanchard et al. (1979). The 
specific activities of the preparations varied between 2.0 and 3. 7 nmol of a-BgTx 
binding sites mg-1 of protein. The concentration of AChR was taken to be half 
of the concentration of a-BgTx sites. 
Synthesis of p-Thiocyanodimethylaniline. Synthesis of p-thiocyanodimethyl-
aniline was accomplished by the method of Brewster & Schroeder (1943). 
Synthesis of p-Thiocyanophenyltrimethyl Ammonium Iodide. 2.3 ml of iodo-
methane was added to 3 g of p-thiocyanodimethylaniline in 12 ml of dry benzene. 
The vessel was sealed. After 7 days at room temperature, the crystalline product 
was collected on a sintered glass funnel. After removal of the remaining solvent in 
vacuo, the product was recrystallized in absolute ethanol. Any remaining ethanol 
was removed in vacuo. The yield was 0.75 g (14%) of white crystals, m.p. 153-
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154°. Anal. calcd. for C10H13N2S: C, 37.50%; H, 4.06; N, 8.75. Found: C, 
37.35%; H, 4.04; N, 8.56. 1H NMR (C2HC13 ): b 3.70 (s, 9H), 7.99 (d, 2H, J=9.2 
Hz), 7.89 (d, 2H, J=8.7 Hz). IR (KBr): 3453 (w), 3009 (w), 2155 (m), 1489 (s), 
1468 (m), 1455 (w), 1120 (w), 1009 (m), 930 (m), 843 (m), and 825 (m) cm- 1 . 
>-max (10 mM sodium borate buffer, pH 9.2), 230 nm, e=19,600. 
Synthesis of !!-Nitro-5-thiocyanobenzoic Acid. NTCB was synthesized accord-
ing to the method of Degani & Patchornik (1971). 
22 Na+ Flux Assay. Membrane vesicles were suspended in BSA solution (10 
mg m1- 1) and incubated for 15-20 min at 22°. The membrane vesicles were then 
pelleted by centrifugation at 40,000 g for 50 minutes. This treatment produces 
sealed membrane vesicles, probably by removal of free fatty acids resulting from 
hydrolysis of lipids during the extraction at pH 11. The pellets were resuspended 
in 50 mM sodium cacodylate buffer containing 100 mM NaCl adjusted to pH 6.5. 
The membranes were pelleted by centrifugation and resuspended in the the same 
buffer containing 15 µCi m1- 1 of 22 Na+ and subjected to two cycles of freeze thaw 
to allow equilibration of 22 Na+ inside and outside of the vesicles. These vesicles 
were assayed for carbamylcholine and TPMA induced 22 Na+ efflux by the method 
of Wu & Raftery (1979). The 22 Na+ retained in the vesicles was determined at 
10, 20, 30, and 40 sec after the addition of agonist and averaged. 
UV Spectra of TPMA and the Product of Reduction. The wavelength of max-
imum absorption of TPMA is 230 nm and the extinction coefficient is 19,600 in 
10 mM sodium borate buffer, pH 9.2. After reduction of 50 µM TPMA with 80 
µM cysteine in 10 mM sodium borate buffer, pH 9.2, the >-max and the extinction 
coefficient of the product (presumably the thiolate anion) are 275 nm and 16,700, 
respectively. 
Determination of the Reaction Rates of NTCB and TPMA with Sulfhydryl 
Reagents. NTCB or TPMA was reacted with equimolar concentrations of cysteine 
or ,B-mercaptoethanol in 10 mM sodium borate buffer, pH 9.2. The -NTCB re-
actions were monitored by the increase in absorbance at 412 nm and the TPMA 
reactions were monitored by the increase in absorbance at 275 nm. The second-
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order reaction constants were determined by plotting the reciprocal of the product 
concentration against time. The slopes of the plot, which are equivalent to the 
second-order rate constants, were determined by a linear least squares analysis. 
Cleavage Reactions. All cleavage reactions were performed in 100 mM sodium 
borate buffer (pH 9.2) in a final volume of 1.0 ml at 37° for 20 hr. Preliminary 
experiments revealed optimal cleavage occurred in about 20 hr. Except for the 
membrane vesicle suspension, all reagents were dissolved in 100 mM sodium borate 
buffer (pH 9.2). The stock membrane vesicles suspension never exceeded 20% of 
the cleavage reaction final volume. Stock solutions of 10 and 100 mM TPMA and 
NTCB dissolved in 100 mM sodium borate buffer (pH 9.2) were stored at -80°. 
After cleavage under conditions described in the figure legends, the membranes 
were centrifuged for 15 min in an Eppendorf centrifuge. The pellets were then 
dissolved in 100 µl of gel electrophoresis sample buffer with dithiothreitol (7 .5 mg 
m1- 1). 25 µl of these samples were loaded on Laemmli gels . 
Cyanylation at pH 8.0 in the presence of PTA. The cyanylation reactions at 
pH 8.0 were performed in 10 mM Hepes buffer containing 35 mM NaN0 3 and 
0.02% NaN3 in a final volume of 1 ml at 37° for 14 hr with conditions described in 
the figure legends. Stock solutions of TPMA and PTA were dissolved in the pH 8.0 
buffer and stored at -80°. After centrifugation in an Eppendorf centrifuge for 15 
min, the pellets were then resuspended in 1 ml of 100 mM sodium borate (pH 9.2) 
and incubated at 37° for 20 hr. Preparation of the samples for gel electrophoresis 
was done as already described. 
Multiple Additions of TPMA. The cleavage reaction was performed in 100 mM 
sodium borate (pH 9.2) with 250 µM TPMA and 1 µM AChR in a final volume of 
lml for 21 hr. Two subsequent additions of an identical amount of TPMA (from 
a 10 mM stock solution) were added at 7 and 14 hr. Preparation of the samples 
for gel electrophoresis was done as already described. 
Gel Electrophoresis. NaDodS0 4-polyacrylamide gel electrophoresis was per-
formed using the system of Laemmli (1970) with 12% polyacrylamide slab gels. 
These gels were stained with 0.5% Coomassie Blue R-250 in 10% acetic acid/25% 
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propanol/65% H2 0 and destained in the same solvent without the dye. Gels were 
scanned using a LKB Ultroscan XL Laser Densitometer. Heights of the peaks 
were used to calculate a relative cleavage value. The smallest peak of a gel was 
set equal to 0 and the largest peak was set equal to 1.0. 
RESULTS 
The synthesis of TPMA is shown in Figure 1. The IR spectrum exhibits a 
sharp absorption band at 2155 cm- 1 (Figure 2). A sharp and medium intensity 
band between 2170-2130 cm- 1 is characteristic of an aryl thiocyanate, whereas an 
aryl isothiocyanate has a broad and strong band between 2105-2060 (Ben-Efraim, 
1977) . The 1 H NMR spectrum is shown in Figure 3. 
Upon reaction with cysteine, a new absorbance peak appears (>.max = 275 
nm), which is presumably the absorbance peak of the thiolate (Figure 4). This 
reaction of TPMA (I) with sulfhydryl reagents presumably generates the thiolate 
ion (II). The second-order reactions of TPMA and NTCB with cysteine have 
R-SH 
I II 
rate constants of 21 mM- 1 min- 1 and 14 mM- 1 min- 1 , respectively (Figure 5). 
The reactions of TPMA and NTCB with ,8-mercaptoethanol have second-order 
rate constants of 23 mM- 1 min- 1 and 15 mM- 1 min- 1 , respectively (Figure 
6). Although the thiolate leaving group of NTCB is resonance stabilized by the 
para nitro group, the thiolate leaving group of the TPMA reaction is probably 
stabilized by an electron inductive effect of the quarternary ammonium group. As 
reactivities of the two compounds with sulfhydryl reagents are almost equivalent 
(the rate constant for TPMA is about 1.5 fold greater than the rate constant for 
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FIGURE 4: The UV spectrum of TPMA before (top) and after (bottom) reaction 
with cysteine as described in Materials and Methods. 
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FIGURE 5: Reaction of equimolar concentrations (17 µM) of TPMA and cysteine 









FIGURE 6: Reaction of equimolar concentrations (17 µM) of TPMA and /3-
mercaptoethanol ( •) and NTCB and /3-mercaptoethanol (•). 
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NTCB), TPMA should cyanylate cysteine residues as efficiently as NTCB. 
TPMA induces cation flux in AChR enriched vesicles and this flux is antag-
onized by a-bungarotoxin (Figure 7). These flux experiments demonstrate that 
TPMA is an agonist for the AChR. 
The reaction of TPMA with AChR yields two products with Mr of 26K and 
22K (Figure 8). The concentration dependence of the cleavage was studied for 
both TPMA and NTCB, in order to contrast the affinity reagent (TPMA) to a 
non-affintiy reagent (NTCB) of similar chemical reactivity (Figures 9 and 10). The 
relative yields of cleavage product were determined by scanning the gels (Figure 
11). The concentrations where 50% cleavage occurs for TPMA and NTCB are 
about 150 µM and 1.5 mM, respectively. As there is an order of magnitude differ-
ence in the concentration dependence of the cleavage reaction, it is likely TPMA 
binds specifically to and subsequently cleaves the AChR. The concentration de-
pendence of the cleavage by TPMA is indicative of its binding to a site for agonists 
with relatively low affinity. Conversely, the equilibrium dissociation constant for 
the binding sites (high affinity) on the 40K subunits are in the range of 1 nM to 
100 nM for agonists under equilibrium conditions. 
The cleavage of AChR by TPMA is blocked by stoichiometric quantities of 
a-bungarotoxin with a-bungarotoxin binding sites (Figure 12). The formation of 
a product with Mr of about 68K is correlated with the blockage of cleavage. This 
is most likely to be a crosslinked product between the SK dalton a-bungarotoxin 
and the 60k subunit. This result suggests the site of cleavage is contained in the 
60K subunit. The yield of the 26K and 22K dalton products of the cleavage re-
action are reduced by inclusion of the agonist, phenyltrimethylammonium iodide 
(PTA) (Figure 13). The cleavage reaction involves two consecutive steps, cyany-
lation of the protein followed by cleavage of the peptide bond. As cleavage is 
probably the rate limiting step and PTA may only compete with cyanylation, the 
competition experiment must be done in a time range before the cyanylation goes 
to completion. Difficulty arises in generating sufficient cleavage in a short enough 
time for blockage of the cyanylation reaction by agonist. In order to eliminate this 
-112-
FIGURE 7: Agonist-induced flux of TPMA. 22 Na+-loaded vesicles were assayed 
for 22 Na+ retained in vesicles as a function of time after mixing with agonist by 
the method of Wu & Raftery (1979). 0 µM agonist (A), 100 µM TPMA (B), 
1 mM TPMA (C), 100 µM carbamylcholine (D), 0.4% Triton X-100 (E), excess 
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FIGURE 8: The reaction of TPMA with 1 µM AChR. Lane 1, 0 µM TPMA; lane 











FIGURE 9: The TPMA concentration dependence of cleavage of 1 µM AChR. 
Lanes 1-12; 0, 10, 50, 100, 150, 200, 250, 300, 400, 600, 1000, and 2000 µM 
TPMA, respectively. 
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FIGURE 10: The NTCB concentration dependence of cleavage of 1 µM AChR. 
Lanes 1-12; 0, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0, 3.0, 5.0, and 7.5 mM NTCB 
respectively. 
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FIGURE 11: The relative yield of the 28K dalton product is plotted against the 
concentration of either TPMA ( •) or NTCB (•). Data was gathered by scanning 











FIGURE 12: Blockage of the reaction of 250 µM TPMA and 0.5 µM AChR with 
stoichiometric quantities of a:-bungarotoxin. Lanes 1-6; 0, 0.25, 0.50, 0.75, 1.0, 











FIGURE 13: Decrease in the yield of the cleavage reaction of 250 µM TPMA with 
1.0 µM AChR by the addition of PTA. Lanes 1-9; 0, 0.5, 1.0, 2.0, 4.0, 5.0, 6.0, 7.0, 
and 8.0 mM PTA. Lane 10 is a control lacking TPMA and TP A, which indicates 
the background cleavage in the absence of TPMA. 
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problem, the cyanylation step was performed in the presence of agonist, followed 
by centrifugation to remove the TPMA and PTA. Then the pellets were taken up 
in the cleavage buffer to effect cleavage. Inclusion of PTA during the cyanylation 
reaction reduces the yield of the cleavage (Figure 14). Separation of the cleav-
age into two steps should prove useful in further investigations on the kinetics of 
the cyanylation. As a-bungarotoxin is a competitive antagonist and PTA is an 
agonist, it is probable the cleavage reaction is taking place at an agonist binding 
site. 
The 60k subunit is degraded most rapidly and to a greater extent than the 
other subunits. Since TPMA is not stable over the entire time course of the reac-
tion, multiple additions of TPMA were used to increase the yield of the reaction 
(Figure 15 and 16). As the 60K subunit is degraded extensively, this indicates the 
site of cleavage is most likely in the 60K subunit. It is probable that there is a 
low-affinity binding site for agonists on the 60K subunit. 
DISCUSSION 
An affinity cleavage reagent requires the linking of a peptide bond cleaving 
functionality with a ligand that binds to a specific site. As PTA is an agonist for 
the AChR, it is not surprising that TPMA is also an agonist. In addition, the 
stabilization of the thiolate leaving group by the positively charged quarternary 
ammonium group allows the reagent to efficiently cyanylate proteins. 
A model depicting the interaction of the cationic TPMA with an amomc 
agonist binding site is shown in Figure 17. The likely candidates for the site of 
cleavage in the 60K subunit are cysteine residues 230, 252, and 301 based on 
the Mr of the cleavage products [residues are numbered according to Noda et al. 
(1983b)]. Cysteine residue 252 is unique to the 60K subunit, whereas cysteine 
residue 301 is conserved in the 60K and 65K subunits. Cysteine residue 230 is 
conserved in all four subunits. Preliminary experiments on the rate of cyanylation 
of the AChR receptor by TPMA indicate the reaction is significantly slower than 
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FIGURE 14: Decrease in the yield of the cleavage reaction of 500 µM TPMA with 
1.0 µM AChR by the addition of PTA at pH 8.0 as described in Materials and 
Methods. Lanes 1-5; O, 0.1, 1.0, 5.0, and 10.0 mM PTA. 
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FIGURE 15: Multiple additions of TPMA to increase the yield of the cleavage 
reaction. Conditions are described in Materials and Methods section. Lanes 1, No 









FIGURE 16: A gel scan of the reaction of AChR with multiple additions of TPMA. 
Conditions are described in Materials and Methods section. No TPMA added (a) 
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FIGURE 17: A model depicting the interaction of the cationic TPMA with an 
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the reaction with free cysteine. This reaction is not blocked by the alkylation of 
the AChR receptor with iodoacetamide during the preparation. Therefore, the 
cysteine residue that reacts with TPMA is not exposed to the aqueous phase. It 
is either buried in a hydrophobic pocket of the protein or the lipid bilayer, either 
of which could be near or contribute to an agonist binding site. 
Labeling of the Torpedo californica AChR with N-phenylmaleimide inhibits 
the ion-channel activity of the AChR (Yee et al. 1986). As treatment with iodoac-
etamide was also included in the preparation of the AChR, this site is not exposed 
to the aqueous phase. The 60K (I) subunit incorporated the most label during 
the reaction with [3 H]N-phenylmaleimide. This preferential labeling of the 60K 
subunit with a hydrophobic sulfhydryl labeling reagent may be the same site at 
which TPMA is reacting. 
Although the affinity labeling studies with BrACh and MBTA have conclu-
sively demonstrated the existence of agonist binding sites on the 40K subunit, the 
dependence of labeling on the presence of an easily reducible disulfide bond may 
not allow labeling of all agonist binding sites. Kao & Karlin (1986) have demon-
strated cysteine residues 192 and 193 in the 40K subunit form a disulfide bond 
which, after reduction, are the residues specifically labeled by MBTA. Witzemann 
and Raftery (1977), using the more general photoaffinity label, DAPA, found both 
the 40K and the 60K subunits were labeled. This labeling was specifically blocked 
by both a-bungarotoxin and DAP. Our results are consistent with this earlier 
finding. 
Mishina et al. (1986), by expression of AChR in a Xenopus oocyte system, 
have found that receptors with different conductance and gating properties result 
when oocytes are injected with subunit-specific mRNA for the a, /3, /, and o 
subunits or the a, /3, /, and f. subunits of calf. These results indicate the / 
subunit (in calf) is involved in determining gating and conductance properties . 
The possibility arises that a low-affinity agonist binding site on the 60K subunit 
may also be involved in gating properties of the AChR. The simplest explanation 
is the occupation of this site may be linked to channel opening. 
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The finding by Catsimpoolas & Wood (1966) that scission of a disulfide bond 
by cyanide yields a sulfhydryl and a thiocyano group, which subsequently effects 
cleavage of the peptide bond, prompted the development of a reagent which could 
cyanylate cysteine residues in high yield. NTCB cyanylates cysteine residues in 
high yield, since the resonance stabilized thiolate is a good leaving group (Figure 
18). A mechanism for the cleavage of the peptide bond, which is catalyzed by 
hydroxide ion, has been proposed by Jacobsen et al. (1973) (Figure 19). 
The demonstration of sequence homology between all four of the AChR sub-
units (Raftery et al. 1980; Noda et al., 1982, 1983a,b) supports the notion that 
multiple agonist binding sites exist. Evidence for sites other than those labeled 
by the affinity reagents, BrACh and MBTA, has been aquired by monitoring flu-
orescent changes of a covalently bound probe (Dunn & Raftery, 1982). Specific 
labeling of both the 40K and 60K subunits by the photoaffinity probe, DAP A, 
indicates there may be a binding site on the 60K subunit. In this communication, 
the cleavage of a peptide bond by an affinity cleavage reagent provides evidence 
for a low-affinity binding site on the 60K subunit. 
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FIGURE 18: Cyanylation and subsequent cleavage of a protein with NTCB or 
TPMA. 
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